Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.

KSG Kim SungGuh, PMY Park MiYoung… - 2008 - cabidigitallibrary.org
Carcinoembryonic antigen (CEA) is expressed on human colon carcinomas, is well
characterized, and continues to be a promising target for cancer immunotherapy in humans …

Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination

SG Kim, MY Park, CH Kim, HJ Sohn, HS Kim, JS Park… - Vaccine, 2008 - Elsevier
Carcinoembryonic antigen (CEA) is expressed on human colon carcinomas, is well
characterized, and continues to be a promising target for cancer immunotherapy in humans …

Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli

MY Bae, NH Cho, SY Seong - Clinical & Experimental …, 2009 - academic.oup.com
Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has
been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific …

[PDF][PDF] Enhanced Induction of CEA Specific Tumor Immunity by TatCEA Fusion Protein.

CH An, WK Kang, ST Oh, HI Cho… - Journal of the Korean …, 2003 - coloproctol.org
PURPOSE The human carcinoembryonic antigen (CEA) is expressed in several tumor
types, including colorectal cancer, and is a tumor-associated antigen used as a target for …

Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti …

HS Kim, CH Kim, MY Park, JS Park, HM Park, HJ Sohn… - Immunology letters, 2010 - Elsevier
Because multiple tumor antigens, including carcinoembryonic antigen (CEA) and survivin
(SVV), have been frequently observed in human colorectal cancer, we investigated whether …

Co‐administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG‐oligodeoxynucleotide induces potent antitumor immunity

SJ Woo, CH Kim, MY Park, HS Kim, HJ Sohn… - Cancer …, 2008 - Wiley Online Library
Although dendritic cells (DC) have been well demonstrated as a strong cellular adjuvant for
a tumor vaccine, there are several limitations for clinical application. A protein‐based …

Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA …

LH Lund, K Andersson, B Zuber, A Karlsson… - Cancer gene …, 2003 - nature.com
Abstract Carcinoembryonic antigen (CEA, CEACAM5) is expressed on several human
carcinomas including colon cancer. CEA contains signal peptides that target the protein …

Induction of CEA-specific Cytotoxic T Lymphocytes by Murine Dendritic Cells Expressing CEA

EH Won, CH Kim, MY Park, HI Cho, ST Oh… - Immune …, 2003 - koreascience.kr
Background: Carcinoembryonic antigen (CEA) is well-known soluble tumor marker
frequently detectable in peripheral blood of carcinoma patients and considered as good …

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA

E Eppler, H Hörig, HL Kaufman, P Groscurth… - European Journal of …, 2002 - Elsevier
The feasibility of dendritic cells (DC) for cancer immunotherapy after transfection by
electroporation with mRNA encoding the human carcinoembryonic antigen (CEA) was …

A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer …

E Ahn, H Kim, KT Han, JI Sin - Cancer letters, 2015 - Elsevier
Human colon cancers express carcinoembryonic antigen (CEA). Thus, CEA has been
considered as a potential vaccine target for immune therapy against colon cancer. In this …